Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
N2586 | Lestaurtinib | 0.3 | uM | IGF-I | 100 | ug/mL | 1 | IL-9 | 64.0 | 71 | |
N2586 | Ruxolitinib | 0.3 | uM | IGF-I | 100 | ug/mL | 1 | IL-9 | 76.0 | 47 | |
N2586 | Tofacitinib | 0.3 | uM | IGF-I | 100 | ug/mL | 1 | IL-9 | 68.0 | 39 | |
N2586 | IKK16 | 2.0 | uM | IGF-I | 100 | ug/mL | 1 | IL-9 | 57.0 | 79 | |
N2586 | 1 | IL-9 | 77.0 | 96 | |||||||
RA2159 | Adiponectin | 5 | ng/mL | 1 | IL-9 | 58.0 | 79 | ||||
RA2159 | PD184352 | 0.1 | uM | Adiponectin | 5 | ng/mL | 1 | IL-9 | 57.5 | 68 | |
RA2159 | Lestaurtinib | 0.3 | uM | Adiponectin | 5 | ng/mL | 1 | IL-9 | 56.0 | 61 | |
RA2159 | Ruxolitinib | 0.3 | uM | Adiponectin | 5 | ng/mL | 1 | IL-9 | 63.0 | 63 | |
RA2159 | Tofacitinib | 0.3 | uM | Adiponectin | 5 | ng/mL | 1 | IL-9 | 73.0 | 64 | |
RA2159 | IKK16 | 2.0 | uM | Adiponectin | 5 | ng/mL | 1 | IL-9 | 52.5 | 74 | |
N2586 | Adiponectin | 5 | ng/mL | 1 | IL-9 | 61.0 | 71 | ||||
N2586 | PD184352 | 0.1 | uM | Adiponectin | 5 | ng/mL | 1 | IL-9 | 70.0 | 53 | |
N2586 | Lestaurtinib | 0.3 | uM | Adiponectin | 5 | ng/mL | 1 | IL-9 | 64.5 | 56 | |
N2586 | Ruxolitinib | 0.3 | uM | Adiponectin | 5 | ng/mL | 1 | IL-9 | 73.5 | 66 | |
N2586 | Tofacitinib | 0.3 | uM | Adiponectin | 5 | ng/mL | 1 | IL-9 | 66.5 | 58 | |
N2586 | IKK16 | 2.0 | uM | Adiponectin | 5 | ng/mL | 1 | IL-9 | 71.0 | 45 | |
RA2159 | Leptin | 1 | ng/mL | 1 | IL-9 | 63.0 | 89 | ||||
RA2159 | PD184352 | 0.1 | uM | Leptin | 1 | ng/mL | 1 | IL-9 | 70.0 | 65 | |
RA2159 | Lestaurtinib | 0.3 | uM | Leptin | 1 | ng/mL | 1 | IL-9 | 56.0 | 59 | |
RA2159 | Ruxolitinib | 0.3 | uM | Leptin | 1 | ng/mL | 1 | IL-9 | 60.5 | 82 | |
RA2159 | Tofacitinib | 0.3 | uM | Leptin | 1 | ng/mL | 1 | IL-9 | 56.0 | 71 | |
RA2159 | IKK16 | 2.0 | uM | Leptin | 1 | ng/mL | 1 | IL-9 | 53.0 | 52 | |
N2586 | Leptin | 1 | ng/mL | 1 | IL-9 | 56.0 | 58 | ||||
N2586 | PD184352 | 0.1 | uM | Leptin | 1 | ng/mL | 1 | IL-9 | 60.0 | 49 |